HSA
MDCO

Hussman Strategic Advisors’s Medicines Co MDCO Stock Holding History

Hussman Strategic Advisors’s Portfolio MDCO Stock Details MDCO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-67,000
Closed -$1.9M – 222
2014
Q1 		$1.9M Sell
67,000
-37,000
-36% -$1.22M 0.14% 112
2013
Q4 		$4.02M Hold
104,000
– – 0.29% 108
2013
Q3 		$3.49M Sell
104,000
-409,000
-80% -$13M 0.19% 115
2013
Q2 		$15.8M Buy
+513,000
New +$17.2M 0.72% 68

Other funds holding MDCO

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
PC
PointState Capital New York $7.9B AUM 42.31% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BM
Bridger Management New York $128M AUM 9.54% 1-Year Est. Return

Hussman Strategic Advisors's MDCO Position: Q2 2014 in Review

Hussman Strategic Advisors sold out of Medicines Co (MDCO) in Q2 2014, closing a stake of 67,000 shares — an estimated $1.9M sold.

Hussman Strategic Advisors first reported a position in MDCO in Q2 2013 and held it in 4 quarters. The position peaked at $15.8M in Q2 2013. 152 funds tracked by Wall St. Rank hold MDCO as of Q2 2014.

  • Hussman Strategic Advisors reported no remaining Medicines Co position as of Q2 2014 after selling out during the quarter.
  • Hussman Strategic Advisors sold 67,000 Medicines Co shares in Q2 2014, an estimated $1.9M.
  • Hussman Strategic Advisors first reported a position in Medicines Co in Q2 2013 and held it in 4 quarters.
  • Hussman Strategic Advisors's Medicines Co position peaked at $15.8M in Q2 2013.
  • 152 funds tracked by Wall St. Rank held Medicines Co as of Q2 2014.

Based on Hussman Strategic Advisors's 13F filing for Q2 2014, filed 1 Aug 2014.